Arena Pharmaceuticals, Inc. To Present At The UBS Global Specialty Pharmaceuticals Conference On Tuesday, April 25, 2006
Published: Apr 20, 2006
SAN DIEGO, April 19 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. announced today that it will present at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, April 25, 2006, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) at the Grand Hyatt Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, will provide a corporate overview and update on Arena and its clinical development and discovery programs.
A live webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. Replays of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
Contacts: Jack Lief Media: President and CEO Carin Canale Porter Novelli Life Sciences 858.527.3498 David Walsey Director, Corporate Communications Arena Pharmaceuticals, Inc. 858.453.7200, ext. 1682Arena Pharmaceuticals, Inc.
CONTACT: Jack Lief, President and CEO, or David Walsey, Director,Corporate Communications, ext. 1682, both of Arena Pharmaceuticals, Inc.,+1-858-453-7200; or Media, Carin Canale of Porter Novelli Life Sciences,+1-858-527-3498, for Arena Pharmaceuticals, Inc.
Web site: http://www.arenapharm.com/